These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 38763180)
1. Role of fragile X messenger ribonucleoprotein 1 in the pathophysiology of brain disorders: a glia perspective. D'Antoni S; Spatuzza M; Bonaccorso CM; Catania MV Neurosci Biobehav Rev; 2024 Jul; 162():105731. PubMed ID: 38763180 [TBL] [Abstract][Full Text] [Related]
3. Unstable mutations in the FMR1 gene and the phenotypes. Loesch D; Hagerman R Adv Exp Med Biol; 2012; 769():78-114. PubMed ID: 23560306 [TBL] [Abstract][Full Text] [Related]
4. [Fragile X syndrome and FMR1-dependent diseases - clinical presentation, epidemiology and molecular background]. Landowska A; Rzońca S; Bal J; Gos M Dev Period Med; 2018; 22(1):14-21. PubMed ID: 29641417 [TBL] [Abstract][Full Text] [Related]
5. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo. Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586 [TBL] [Abstract][Full Text] [Related]
6. CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size. Ludwig AL; Espinal GM; Pretto DI; Jamal AL; Arque G; Tassone F; Berman RF; Hagerman PJ Hum Mol Genet; 2014 Jun; 23(12):3228-38. PubMed ID: 24463622 [TBL] [Abstract][Full Text] [Related]
7. Clinical, molecular, and pharmacological aspects of FMR1 related disorders. Pugin A; Faundes V; Santa María L; Curotto B; Aliaga S; Salas I; Soto P; Bravo P; Peña MI; Alliende MA Neurologia; 2017 May; 32(4):241-252. PubMed ID: 25529181 [TBL] [Abstract][Full Text] [Related]
8. Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 gene. Nobile V; Palumbo F; Lanni S; Ghisio V; Vitali A; Castagnola M; Marzano V; Maulucci G; De Angelis C; De Spirito M; Pacini L; D'Andrea L; Ragno R; Stazi G; Valente S; Mai A; Chiurazzi P; Genuardi M; Neri G; Tabolacci E Hum Genet; 2020 Feb; 139(2):227-245. PubMed ID: 31919630 [TBL] [Abstract][Full Text] [Related]
9. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome. Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828 [TBL] [Abstract][Full Text] [Related]
10. High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome. Basuta K; Schneider A; Gane L; Polussa J; Woodruff B; Pretto D; Hagerman R; Tassone F Am J Med Genet A; 2015 Sep; 167A(9):2154-61. PubMed ID: 25920745 [TBL] [Abstract][Full Text] [Related]
11. Fragile X syndrome and associated disorders: Clinical aspects and pathology. Salcedo-Arellano MJ; Dufour B; McLennan Y; Martinez-Cerdeno V; Hagerman R Neurobiol Dis; 2020 Mar; 136():104740. PubMed ID: 31927143 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients. Pagano G; Lyakhovich A; Pallardó FV; Tiano L; Zatterale A; Trifuoggi M Mol Biol Rep; 2024 Apr; 51(1):480. PubMed ID: 38578387 [TBL] [Abstract][Full Text] [Related]
14. Astroglial-targeted expression of the fragile X CGG repeat premutation in mice yields RAN translation, motor deficits and possible evidence for cell-to-cell propagation of FXTAS pathology. Wenzel HJ; Murray KD; Haify SN; Hunsaker MR; Schwartzer JJ; Kim K; La Spada AR; Sopher BL; Hagerman PJ; Raske C; Severijnen LWFM; Willemsen R; Hukema RK; Berman RF Acta Neuropathol Commun; 2019 Feb; 7(1):27. PubMed ID: 30808398 [TBL] [Abstract][Full Text] [Related]
15. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles. Wang JY; Hessl D; Schneider A; Tassone F; Hagerman RJ; Rivera SM JAMA Neurol; 2013 Aug; 70(8):1022-9. PubMed ID: 23753897 [TBL] [Abstract][Full Text] [Related]